These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8493458)

  • 1. A model of reversible uremia employing isogenic kidney transplantation in the rat. Reversibility of secondary hyperparathyroidism.
    Lewin E; Colstrup H; Pless V; Ladefoged J; Olgaard K
    Scand J Urol Nephrol; 1993; 27(1):115-20. PubMed ID: 8493458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of experimental secondary hyperparathyroidism.
    Lewin E; Wang W; Olgaard K
    Kidney Int; 1997 Nov; 52(5):1232-41. PubMed ID: 9350646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
    Lewin E; Garfia B; Recio FL; Rodriguez M; Olgaard K
    J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involution of the parathyroid glands after renal transplantation.
    Lewin E
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):363-71. PubMed ID: 12815332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone regulation in normal and uremic rats. Reversibility of secondary hyperparathyroidism after experimental kidney transplantation.
    Lewin E
    Dan Med Bull; 2004 May; 51(2):184-206. PubMed ID: 16009056
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
    Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
    Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium and phosphorus metabolism in uremia and renal transplantation: an experimental model.
    Mitchell TS; Lee S; Gittes RF
    Invest Urol; 1974 Nov; 12(3):186-92. PubMed ID: 4613687
    [No Abstract]   [Full Text] [Related]  

  • 9. Parathyroid hormone dependent T cell proliferation in uremic rats.
    Lewin E; Ladefoged J; Brandi L; Olgaard K
    Kidney Int; 1993 Aug; 44(2):379-84. PubMed ID: 8377382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of parathyroid mass on the regulation of PTH secretion.
    Lewin E; Olgaard K
    Kidney Int Suppl; 2006 Jul; (102):S16-21. PubMed ID: 16810305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
    Jablonski G; Klem KH; Attramadal A; Dahl E; Rønningen H; Gautvik KM; Haug E; Gordeladze JO
    Biosci Rep; 1993 Oct; 13(5):275-87. PubMed ID: 8142613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new experimental model for secondary hyperparathyroidism.
    Sancho JJ; Duh QY; Oms L; Sitges-Serra A; Hammond ME; Arnaud CD; Clark OH
    Surgery; 1989 Dec; 106(6):1002-8. PubMed ID: 2588105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.
    Jablonski G; Danielsen CC; Mosekilde L; Gordeladze JO
    Calcif Tissue Int; 1994 Oct; 55(4):281-7. PubMed ID: 7820779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.
    Li X; Yu L; Asuncion F; Grisanti M; Alexander S; Hensley K; Han CY; Niu QT; Dwyer D; Villasenor K; Stolina M; Dean C; Ominsky MS; Ke HZ; Tomlinson JE; Richards WG
    Bone; 2017 Dec; 105():163-172. PubMed ID: 28867373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistant abnormal serum parathyroid hormone after renal transplantation: correlation between renal graft function.
    Cheng CH; Lian JD; Yang YF; Shu KH; Lu YS; Chen DL
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):81-4. PubMed ID: 2670141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease.
    Jara A; Felsenfeld AJ; Bover J; Kleeman CR
    Kidney Int; 2000 Sep; 58(3):1023-32. PubMed ID: 10972667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus.
    Bover J; Jara A; Trinidad P; Rodriguez M; Felsenfeld AJ
    Bone; 1999 Sep; 25(3):279-85. PubMed ID: 10495131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG; Coburn JW; Popovtzer MM; Shinaberger JH; Maxwell MH; Kleeman CR
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.